Yihai starts IPO as Fosun Pharma eyes spin-off
Yihai International Holding launched its Hong Kong IPO last Thursday to raise HK$$889.2m ($114.6m), with the company choosing to go it alone without the aid of cornerstone investors.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: